Epithelial-mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine-rich alpha-2 glycoprotein.


Journal

Cancer science
ISSN: 1349-7006
Titre abrégé: Cancer Sci
Pays: England
ID NLM: 101168776

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 28 02 2018
revised: 17 12 2018
accepted: 18 12 2018
pubmed: 24 12 2018
medline: 9 3 2019
entrez: 22 12 2018
Statut: ppublish

Résumé

We previously showed that an inflammation-related, molecule leucine-rich alpha-2 glycoprotein (LRG) enhances the transforming growth factor (TGF)-β1-induced phosphorylation of Smad proteins and is elevated in patients with pancreatic ductal adenocarcinoma (PDAC). As TGF-β/Smad signaling is considered to play a key role in epithelial-mesenchymal transition (EMT), we attempted to clarify the mechanism underlying LRG-related EMT in relation to metastasis in PDAC. We cultured LRG-overexpressing PDAC cells (Panc1/LRG) and evaluated the morphology, EMT-related molecules and TGF-β/Smad signaling pathway in these cells. We also assessed the LRG levels in plasma and resected specimens from patients with PDAC. Inflammatory cytokines induced LRG production in PDAC cells. A spindle-like shape was visualized more frequently than other shapes in Panc1/LRG with TGF-β1 exposure. The expression of E-cadherin in Panc1/LRG was decreased with TGF-β1 exposure. Invasion increased with TGF-β1 stimulation of Panc1/LRG. The phosphorylation of smad2 in Panc1/LRG was increased in comparison with parental Panc1 under TGF-β1 stimulation. In the plasma LRG-high group, the recurrence rate tended to be higher and the recurrence-free survival (RFS) tended to be worse in comparison with the plasma LRG-low group. LRG enhanced EMT induced by TGF-β signaling, thus indicating that LRG has a significant effect on the metastasis of PDAC.

Identifiants

pubmed: 30575211
doi: 10.1111/cas.13918
pmc: PMC6398893
doi:

Substances chimiques

Cadherins 0
Glycoproteins 0
Smad2 Protein 0
TGFB1 protein, human 0
Transforming Growth Factor beta1 0
Leucine GMW67QNF9C

Banques de données

GENBANK
['ab178698']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

985-996

Subventions

Organisme : Japan Agency for Medical Research and Development
ID : 15ek0109045h0002
Organisme : JSPS KAKENHI Grant-in-Aid for Young Scientists (Start-up)
ID : 15H06918
Organisme : Grant-in-Aid for Scientific Research
ID : 17H04215
Organisme : Grant-in-Aid for Scientific Research
ID : 15K10202
Organisme : Bristol-Myers Squibb Foundation

Informations de copyright

© 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.

Références

Eur J Cancer. 2013 May;49(7):1725-40
pubmed: 23298711
Inflamm Bowel Dis. 2012 Nov;18(11):2169-79
pubmed: 22374925
Hepatogastroenterology. 2013 Jun;60(124):904-11
pubmed: 23321032
Int J Cancer. 1998 Jan 19;75(2):284-9
pubmed: 9462720
Int J Cancer. 2015 Sep 1;137(5):1035-46
pubmed: 25604508
Cancer Sci. 2017 Oct;108(10):2052-2060
pubmed: 28746773
J Clin Invest. 2006 Jul;116(7):1843-52
pubmed: 16767220
EMBO J. 2002 Dec 2;21(23):6473-82
pubmed: 12456654
JAMA. 2013 Oct 9;310(14):1473-81
pubmed: 24104372
Neoplasma. 2011;58(5):396-405
pubmed: 21744993
Ann Surg Oncol. 2017 Nov;24(12):3715-3724
pubmed: 28849575
Oncotarget. 2017 Feb 7;8(6):9961-9973
pubmed: 28035069
Ann Gastroenterol Surg. 2017 Apr 25;1(1):5-10
pubmed: 29863129
Arthritis Rheumatol. 2015 May;67(8):2056-60
pubmed: 25917892
Nat Rev Cancer. 2010 Jun;10(6):415-24
pubmed: 20495575
Hepatology. 2005 Dec;42(6):1329-38
pubmed: 16317687
Dig Surg. 2018;35(1):70-76
pubmed: 28482348
Nature. 2013 Jul 18;499(7458):306-11
pubmed: 23868260
Clin Cancer Res. 2000 Jul;6(7):2881-90
pubmed: 10914738
Cardiovasc Res. 2016 Feb 1;109(2):272-82
pubmed: 26678356
Cancer Sci. 2019 Mar;110(3):985-996
pubmed: 30575211
Jpn J Clin Oncol. 2014 Dec;44(12):1172-80
pubmed: 25425728
Br J Cancer. 2011 Oct 25;105(9):1370-8
pubmed: 21970875
Oncotarget. 2015 Feb 20;6(5):3085-97
pubmed: 25609203
Cancer Res. 2001 May 15;61(10):4222-8
pubmed: 11358848
Jpn J Clin Oncol. 1998 Jan;28(1):12-5
pubmed: 9491135
Medicine (Baltimore). 2017 Feb;96(5):e5926
pubmed: 28151872
J Leukoc Biol. 2008 May;83(5):1277-85
pubmed: 18272588
Pancreas. 2015 Jul;44(5):756-63
pubmed: 25931255
PLoS One. 2016 Sep 09;11(9):e0162672
pubmed: 27611322
Oncotarget. 2015 May 10;6(13):11009-22
pubmed: 25826092
Int J Clin Lab Res. 1995;25(1):40-3
pubmed: 7787209
Proc Natl Acad Sci U S A. 1985 Apr;82(7):1906-10
pubmed: 3856868
CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30
pubmed: 26742998
Gastroenterology. 2005 Jun;128(7):2054-65
pubmed: 15940637
J Clin Biochem Nutr. 2014 Jul;55(1):56-61
pubmed: 25120280
Pancreas. 2015 Jan;44(1):93-8
pubmed: 25058884
Int J Cancer. 2016 Mar 1;138(5):1118-28
pubmed: 26413860
Lancet. 2016 Jul 16;388(10041):248-57
pubmed: 27265347
Tumour Biol. 2015 Mar;36(3):1375-84
pubmed: 25680410
J Korean Med Sci. 2014 Sep;29(9):1199-204
pubmed: 25246736
Cancer Chemother Pharmacol. 2014 Feb;73(2):309-15
pubmed: 24258457
Ann Rheum Dis. 2010 Apr;69(4):770-4
pubmed: 19854709
Hepatogastroenterology. 1999 Jan-Feb;46(25):8-15
pubmed: 10228758
Arthritis Res Ther. 2017 Jun 14;19(1):137
pubmed: 28615031
Cell Tissue Res. 2016 Sep;365(3):495-506
pubmed: 27461257
Blut. 1977 Sep 29;35(3):229-39
pubmed: 71929
Hepatobiliary Pancreat Dis Int. 2014 Aug;13(4):371-80
pubmed: 25100121
Biochem Biophys Res Commun. 2009 May 15;382(4):776-9
pubmed: 19324010
Cancer Res. 2015 Jun 1;75(11):2292-304
pubmed: 25840985
J Leukoc Biol. 2002 Sep;72(3):478-85
pubmed: 12223515

Auteurs

Toru Otsuru (T)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Shogo Kobayashi (S)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Hiroshi Wada (H)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Tsuyoshi Takahashi (T)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Kunihito Gotoh (K)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Yoshifumi Iwagami (Y)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Daisaku Yamada (D)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Takehiro Noda (T)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Tadafumi Asaoka (T)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Satoshi Serada (S)

Center for Intractable Immune Disease, Kochi University, Kochi, Japan.

Minoru Fujimoto (M)

Center for Intractable Immune Disease, Kochi University, Kochi, Japan.

Hidetoshi Eguchi (H)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Masaki Mori (M)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Yuichiro Doki (Y)

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.

Testuji Naka (T)

Center for Intractable Immune Disease, Kochi University, Kochi, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH